BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24190613)

  • 1. Effects of sildenafil treatment on patients with Peyronie's disease and erectile dysfunction.
    Ozturk U; Yesil S; Goktug HN; Gucuk A; Tuygun C; Sener NC; Nalbant I; Imamoglu MA
    Ir J Med Sci; 2014 Sep; 183(3):449-53. PubMed ID: 24190613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sildenafil 25 mg ODT + Collagenase Clostridium hystoliticum vs Collagenase Clostridium hystoliticum Alone for the Management of Peyronie's Disease: A Matched-Pair Comparison Analysis.
    Cocci A; Cito G; Urzì D; Minervini A; Di Maida F; Sessa F; Mari A; Campi R; Falcone M; Capece M; Morelli G; Cacciamani G; Rizzo M; Polito C; Giammusso B; Morgia G; Verze P; Salonia A; Cai T; Mirone V; Mondaini N; Russo GI
    J Sex Med; 2018 Oct; 15(10):1472-1477. PubMed ID: 30245025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of erectile dysfunction in patients with Peyronie's disease using sildenafil citrate.
    Levine LA; Latchamsetty KC
    Int J Impot Res; 2002 Dec; 14(6):478-82. PubMed ID: 12494281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the association between erectile rigidity and treatment adherence with sildenafil.
    Mazzola CR; Deveci S; Teloken P; Mulhall JP
    J Sex Med; 2013 Jul; 10(7):1861-6. PubMed ID: 23253943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized open-label trial with a crossover comparison of sexual self-confidence and other treatment outcomes following tadalafil once a day vs. tadalafil or sildenafil on-demand in men with erectile dysfunction.
    Rubio-Aurioles E; Porst H; Kim ED; Montorsi F; Hackett G; Morales AM; Stuckey B; Būttner H; West TM; Huynh NN; Lenero E; Burns P; Kopernicky V
    J Sex Med; 2012 May; 9(5):1418-29. PubMed ID: 22429760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A return to normal erectile function with tadalafil once daily after an incomplete response to as-needed PDE5 inhibitor therapy.
    Kim ED; Seftel AD; Goldfischer ER; Ni X; Burns PR
    J Sex Med; 2014 Mar; 11(3):820-30. PubMed ID: 23841532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of doxazosin and sildenafil exerts an additive relaxing effect compared with each compound alone on human cavernosal and prostatic tissue.
    Oger S; Behr-Roussel D; Gorny D; Lecoz O; Lebret T; Denoux Y; Faix A; Leriche A; Wayman C; Alexandre L; Giuliano F
    J Sex Med; 2009 Mar; 6(3):836-47. PubMed ID: 19143907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is There a Point to Performing a Penile Duplex Ultrasound?
    Morgado A; Diniz P; Silva CM
    J Sex Med; 2019 Oct; 16(10):1574-1580. PubMed ID: 31405766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erectile dysfunction following surgical correction of Peyronie's disease and a pilot study of the use of sildenafil citrate rehabilitation for postoperative erectile dysfunction.
    Levine LA; Greenfield JM; Estrada CR
    J Sex Med; 2005 Mar; 2(2):241-7. PubMed ID: 16422892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of PDE5 inhibitors in penile septal scar remodeling: assessment of clinical and radiological outcomes.
    Chung E; Deyoung L; Brock GB
    J Sex Med; 2011 May; 8(5):1472-7. PubMed ID: 21324095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
    Ali ST
    Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca2+ -activated K+ channel (KCa) stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction.
    González-Corrochano R; La Fuente J; Cuevas P; Fernández A; Chen M; Sáenz de Tejada I; Angulo J
    Br J Pharmacol; 2013 May; 169(2):449-61. PubMed ID: 23441682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical prostatectomy: results of a randomized double-blind trial with placebo.
    Pavlovich CP; Levinson AW; Su LM; Mettee LZ; Feng Z; Bivalacqua TJ; Trock BJ
    BJU Int; 2013 Oct; 112(6):844-51. PubMed ID: 23937708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated With Erectile Dysfunction and the Peyronie's Disease Questionnaire in Patients With Peyronie Disease.
    Serefoglu EC; Smith TM; Kaufman GJ; Liu G; Yafi FA; Hellstrom WJG
    Urology; 2017 Sep; 107():155-160. PubMed ID: 28554517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial antioxidant administration ameliorates the erectile response to PDE5 regardless of the extension of the atherosclerotic process.
    Vicari E; La Vignera S; Condorelli R; Calogero AE
    J Sex Med; 2010 Mar; 7(3):1247-53. PubMed ID: 19674252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emotional changes in men treated with sildenafil citrate for erectile dysfunction: a double-blind, placebo-controlled clinical trial.
    Moncada I; Martínez-Jabaloyas JM; Rodriguez-Vela L; Gutiérrez PR; Giuliano F; Koskimaki J; Farmer IS; Renedo VP; Schnetzler G
    J Sex Med; 2009 Dec; 6(12):3469-77. PubMed ID: 19796051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assessment of the efficacy and safety of sildenafil administered to patients with erectile dysfunction referred for posterior urethroplasty: a single-center experience.
    Fu Q; Sun X; Tang C; Cui R; Chen L
    J Sex Med; 2012 Jan; 9(1):282-7. PubMed ID: 21933349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease.
    Conti CR; Pepine CJ; Sweeney M
    Am J Cardiol; 1999 Mar; 83(5A):29C-34C. PubMed ID: 10078540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie's disease.
    Safarinejad MR; Asgari MA; Hosseini SY; Dadkhah F
    BJU Int; 2010 Jul; 106(2):240-8. PubMed ID: 19863517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafil once a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction.
    Buvat J; Büttner H; Hatzimouratidis K; Vendeira PA; Moncada I; Boehmer M; Henneges C; Boess FG
    J Sex Med; 2013 Jun; 10(6):1592-602. PubMed ID: 23551622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.